img
img
Is SCUBE1 helpful to predict the arterial thrombotic risk in patients with multiple myeloma: a preliminary study      
Yazarlar (4)
Elif Akdoğan
Türkiye
Teslime Ayaz
Recep Tayyip Erdoğan Üniversitesi, Türkiye
Prof. Dr. Aynur KIRBAŞ Prof. Dr. Aynur KIRBAŞ
Kırşehir Ahi Evran Üniversitesi, Türkiye
Halil Rakıcı
Türkiye
Devamını Göster
Özet
Background: Signal peptide-CUB-EGF-like domain-containing protein I (SCUBE1) is expressed in vascular endothelium and human platelets. SCUBE I levels are increased in acute arterial thrombosis. Multiple myeloma patients are also at increased risk of arterial thrombotic events. This study aimed to measure SCUBE1 levels in newly diagnosed multiple myeloma patients and to define whether SCUBE1 could be a useful marker determining the arterial thrombotic risk.
Methods: SCUBE1 levels of 32 newly diagnosed multiple myeloma patients and 41 healthy control subjects were measured by enzyme-linked immunosorbent assay.
Results: Plasma SCUBE1 levels of multiple myeloma patients and control subjects were 6.22 +/- 0.9 and 7.95 +/- 1.1 ng/ml, respectively. In the patient group, SCUBE1 levels were significantly lower compared to control subjects (p <0.001).
Conclusions: SCUF3E1 level measuring does not help to predict the arterial thrombotic risk in multiple myeloma patients. The significantly lower levels of SO JF3E1 in multiple myeloma patients are likely to be due to defective platelets and/or increased TNF-alpha cytokines and is another proof of platelet dysfunction seen in these patients.
Anahtar Kelimeler
Signal peptide-CUB-EGF-like domain-containing protein 1 | SCUBE1 | multiple myeloma | arterial thrombosis
Makale Türü Özgün Makale
Makale Alt Türü SSCI, AHCI, SCI, SCI-Exp dergilerinde yayımlanan tam makale
Dergi Adı HIPPOKRATIA
Dergi ISSN 1108-4189 Wos Dergi Scopus Dergi
Dergi Tarandığı Indeksler SCI-Expanded
Dergi Grubu Q4
Makale Dili İngilizce
Basım Tarihi 01-2019
Cilt No 23
Sayı 1
Sayfalar 21 / 24
BM Sürdürülebilir Kalkınma Amaçları
Atıf Sayıları
WoS 1
Google Scholar 2

Paylaş